October 26th 2024
Sun Pharma presented long-term data on Leqselvi 8 mg tablets, showing significant scalp hair regrowth in severe alopecia areata patients.
Patients With Moderate to Severe Alopecia Areata Exhibit Higher Risk of Developing Atopic Dermatitis
July 31st 2024Data from a retrospective analysis demonstrated that patients with moderate to severe alopecia areata are at a higher risk of developing atopic dermatitis compared to those with mild alopecia areata.